Analex Announces Julie Holt as New President Of Advanced Biosystems Subsidiary
Tuesday September 17, 8:15 am ET
ALEXANDRIA, Va., Sept. 17 /PRNewswire-FirstCall/ -- Analex Corporation (OTC Bulletin Board: ANLX - News) today announced that Julie Holt has joined its Advanced Biosystems subsidiary as president. Ms. Holt will lead Advanced Biosystems' operations and business expansion programs, while Dr. Ken Alibek, Vice Chairman and Chief Scientist, will continue to direct all aspects of Advanced Biosystems' scientific and medical research and product development programs.
ADVERTISEMENT
Dr. Alibek said, "We are very fortunate that Julie Holt has joined our team. There has been a strong demand for Advanced Biosystems to provide consulting services in the biodefense field. Until now, our main focus has been on our medical research programs. Now, Ms. Holt is here to guide Advanced Biosystems' expansion and diversification into additional areas." Sterling Phillips, President and Chief Executive Officer of Analex, said, "Ms. Holt brings solid senior management expertise in national security and first responder training programs to Advanced Biosystems." Mr. Phillips added, "Her experience in foreign service and international business also adds a new dimension to the Company's growth."
Ms. Holt recently held senior management positions at Battelle Memorial Institute, specializing in the coordination and expansion of emergency management and hazardous material inter-agency federal government programs. Prior to Battelle, she worked with Bechtel International in Hong Kong, and has also served as a U.S. Department of State foreign service officer with assignments in Asia.
Analex specializes in developing intelligence, systems engineering and biodefense solutions in support of our nation's security. Analex focuses on developing medical defenses and treatments for infectious agents used in biological warfare and terrorism; designing, developing and testing aerospace products and systems; developing innovative technical solutions for the intelligence community; and analyzing and supporting defense systems. The Company's stock trades on the OTC Electronic Bulletin Board under the symbol ANLX. The Company can be found on the Internet at analex.com. Analex investor relations can be contacted at (703) 329-9400 or via email at amber.gordon@analex.com.
PLEASE NOTE: Except for the historical information contained herein, this press release contains forward-looking statements within the meaning of Section 21E of the Securities and Exchange Act of 1934, as amended, that involve a number of risks and uncertainties. These forward-looking statements may be identified by reference to a future period by use of forward-looking terminology such as "anticipate," "expect," "could," "intend," "may" and other words of similar nature. There are certain important factors and risks that could cause results to differ materially from those anticipated by the statements contained herein. Such factors and risks include business conditions and growth in the medical research, pharmaceutical and government contracting arenas and in the economy in general. Competitive factors include the pressures toward consolidation of small government contracts into larger contracts awarded to major, multi-national corporations; and the Company's ability to continue to recruit and retain highly skilled scientific, technical, managerial and sales/marketing personnel. Other risks may be detailed from time to time in the Company's filings with the Securities and Exchange Commission. Analex undertakes no obligation to update or revise any forward-looking statements, whether as a result of new information, future events or otherwise.
--------------------------------------------------------------------------------
Source: Analex Corporation
Email this story - Set a News Alert
ADVERTISEMENTSpecial Offers
· Paying too much for car insurance? Find out
· Order new service online - get an extra $50
· $7.95 Domain Name Registrations & Transfers at Aplus.Net!
· Interest rates won't stay this low forever. Yahoo! Mortgage Center
· Planning to Sell Your Home? Compare REALTORS® Now!
· Rent all the DVDs you want - Try FREE!
Related Quote
ANLX.OB 2.45 -0.25 News
View Detailed Quote
Delayed 20 mins
Quote data provided by Reuters
Related News Stories
· Analex Announces 2nd Quarter 2002 Earnings - PR Newswire (Wed Aug 7)
· Analex's Advanced Biosystems Subsidiary Awarded New $3 Million Biodefense Contract by DARPA - PR Newswire (Thu Aug 1)
· Webcast Alert: Analex Announces Conference Call and Webcast for Second Quarter Earnings - PR Newswire (Wed Jul 31)
· HADRON INC - Quarterly Report (SEC form 10-Q) - EDGAR Online (Wed Nov 14)
More...
--------------------------------------------------------------------------------
· By industry: Biotech, Computers, Medical/pharmaceutical
Top Stories
· Stocks Lower as Profit Worries Reign - Reuters Business Report (2:08 pm)
· McDonald's Warns, Stock Drops 11 Percent - Reuters Business Report (12:20 pm)
· Pfizer Affirms Earnings Outlook - Reuters Business Report (12:26 pm)
· Tyco Report Details Extravagance, Fraud - Reuters Business Report (12:07 pm)
More...
--------------------------------------------------------------------------------
· Most-emailed articles
· Most-viewed articles
Finance Spotlight
· Research Reports
Expert insight at great prices
· MarketTracker
Live streaming quotes for $9.95/mo
--------------------------------------------------------------------------------
Copyright © 2002 Yahoo! Inc. All rights reserved. Privacy Policy - Terms of Service
Copyright © 2002 PR Newswire. All rights reserved. Republication or redistribution of PRNewswire content is expressly prohibited without the prior written consent of PRNewswire. PRNewswire shall not be liable for any errors or delays in the content, or for any actions taken in reliance thereon. |
